Tag: clinical trials

A pharmaceutical company conducting a Phase III clinical trial for a novel oncology drug has been sanctioned by regulatory authorities following the discovery of systematic data manipulation across multiple trial sites. Key Findings The investigation, launched after a whistleblower complaint, revealed several critical issues: Falsified patient records: Approximately 12% of patient enrollment records at three…